Positive step for drug from engineered goat
2009 January 9
In a surprise move, it seems likely the first genetically engineered animal approved for commercial use won’t be a fast-growing salmon, as was expected, but a goat that produces an anti-clotting drug in its milk.
A Food and Drug Administration evaluation released Wednesday found that the drug Atryn is effective and safe.
The report will be presented Friday to FDA’s Blood Products Advisory Board. Made up of outside experts, the panel will vote on whether to approve the application. If approved, the drug will have crossed the first hurdle toward acceptance, says FDA spokeswoman Siobhan DeLancey. There are still more steps in the FDA’s drug-approval process.
No comments yet